And one of the registries that is sponsored by the NHLBI decided to take this question on and really look at whether or not women should be receiving this device. Again, this is a scenario where only one device was originally tested in somatodrol the early trials. The device was too large to actually be implanted in many women. So the evidence wasn't there in order to be able to really provide the clinical impetus to use the device. And actually what we've found as they really kindof delved into this issue, is that in fact there was no difference; and that women had the same degree of benefit from implanting this device after the smaller devices were developed and were able to be used as showing that actually gathering that necessary information basically staved off .